CytoDyn Inc - logo

CytoDyn Inc - Company & Market Research Reports

Following a company allows Research and Markets to customize your experience and provide personalized recommendations.

CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of Human Immunodeficiency Virus (HIV) infection. The company has one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which has finished Phase 2 clinical trials with demonstrated antiviral activity in man. The company is based in Vancouver, Washington.

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2018 - Product Thumbnail Image

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 67 Pages
From
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2018 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 1005 Pages
From
C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2018 - Product Thumbnail Image

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 70 Pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

  • Report
  • 350 Pages
From
PharmaPoint: Human Immunodeficiency Virus (HIV) - Global Drug Forecast and Market Analysis to 2025 - Product Thumbnail Image

PharmaPoint: Human Immunodeficiency Virus (HIV) - Global Drug Forecast and Market Analysis to 2025

  • Report
  • 365 Pages
From
Human Immunodeficiency Virus (HIV): Competitive Landscape to 2026 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV): Competitive Landscape to 2026

  • Report
  • 52 Pages
From
Transplantation Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Transplantation Drug Development Pipeline Review, 2017

  • Report
  • 242 Pages
From
What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other]) - Product Thumbnail Image

What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

  • Report
  • 203 Pages
From
Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2018 - Product Thumbnail Image

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 498 Pages
From
Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2018 - Product Thumbnail Image

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 465 Pages
From
Global Autoinjectors Market (2nd Edition), 2018-2030 - Product Thumbnail Image

Global Autoinjectors Market (2nd Edition), 2018-2030

  • Report
  • 510 Pages
From
Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 2941 Pages
From
Large Volume Wearable Injectors Market (4th Edition), 2018-2030 - Product Thumbnail Image

Large Volume Wearable Injectors Market (4th Edition), 2018-2030

  • Report
  • 348 Pages
From
Prefilled Syringes Market (4th Edition), 2017-2026 - Product Thumbnail Image

Prefilled Syringes Market (4th Edition), 2017-2026

  • Report
  • 525 Pages
From
Global Autoinjectors Market, 2016 - 2026 - Product Thumbnail Image

Global Autoinjectors Market, 2016 - 2026

  • Report
  • 380 Pages
From
Transplant Complications Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Transplant Complications Drug Development Pipeline Review, 2018

  • Report
  • 173 Pages
From
Bone Marrow Transplant Rejection - Pipeline Review, H2 2018 - Product Thumbnail Image

Bone Marrow Transplant Rejection - Pipeline Review, H2 2018

  • Drug Pipelines
  • 487 Pages
From
Bone Marrow Transplant Rejection - Pipeline Review, H1 2018 - Product Thumbnail Image

Bone Marrow Transplant Rejection - Pipeline Review, H1 2018

  • Drug Pipelines
  • 483 Pages
From
CytoDyn Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

CytoDyn Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • 50 Pages
From
Cytodyn Inc (CYDY) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Cytodyn Inc (CYDY) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • 25 Pages
From
Loading Indicator
adroll